If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

Share Price is delayed by 15 minutes
Get Live Data
4.30    0.00 (0.00%)
Bid:
4.20
Ask:
4.40
Spread: 0.20 (4.762%)
Market Cap: £11.06m
TEK Live PriceLast checked at - London Stock Exchange

Intraday TekCapital Share Chart

US Salt forms Strategic Partnership with MicroSalt

6 Feb 2023 07:00

RNS Number : 9421O
Tekcapital plc
06 February 2023
 

6 February 2023

Tekcapital Plc

("Tekcapital" or the "Group")

Portfolio Company Update: MicroSalt, Ltd. ("MicroSalt")

US Salt LLC forms strategic partnership with MicroSalt to provide

 full-flavour, low-sodium salt in bulk, take-home shakers

 

Tekcapital Plc (AIM: TEK), (OTCQB: TEKCF) the UK intellectual property investment group focused on creating valuable products that can improve people's lives, is pleased to announce that MicroSalt has entered into an agreement with US Salt LLC ("US Salt") for the distribution and delivery of MicroSalt's low-sodium solutions.

"We are proud to work with US Salt in their efforts to offer low-sodium solutions to their customer base. US Salt as a leader in salt distribution, offering lower sodium as an active option in its ingredient listing. Excess sodium intake is one of the world's leading health concerns, and we believe that partnerships like this are a great way to expand our efforts to address the sodium reduction challenge." Said Rick Guiney, CEO of MicroSalt"

"US Salt is looking forward to working with MicroSalt® to help with our low-sodium initiatives. Sodium is a worldwide concern in the food industry, and we believe Rick and his team are the industry leaders that can help propel our future growth." Said Bob Jordan, Vice President of Sales & Marketing of US Salt LLC.

This partnership is expected to strengthen each companies' respective market positions as leaders in the sodium reduction effort, through expanding the customer base for MicroSalt and the product offerings for US Salt, with healthy, lower sodium alternatives.

About US Salt LLC

US Salt, LLC is currently responsible for producing and distributing over 90% of the private label, round can salt business in the United States. US Salt currently produces and packs 26-ounce private label table salt, as well as a complete portfolio of quality round can table salt items to meet all salt seasoning needs. To learn more about US Salt, visit www.ussaltllc.com.

 

About MicroSalt, Ltd

MicroSalt, is the developer and manufacturer of a proprietary low-sodium salt called MicroSalt®. We are passionate about improving peoples' lives with better-for-you seasonings and snacks by taking the lead in the industry by providing the best low-sodium salt solution, based on the mechanical transformation of the salt particle itself. This solution is the only one that delivers real salt flavour because it is salt. Our new patented technology produces salt crystals that are approximately one hundred times smaller than typical table salt, delivering a powerful saltiness as the micro-grains dissolve in the mouth, with approximately 50% less sodium consumption. Additionally, the ultra-small particle size enhances product adhesion, which reduces waste and provides improved flavor consistency. MicroSalt® and SaltMe® are registered trademarks of MicroSalt Inc.

 

To learn more about MicroSalt please visit www.microsaltinc.com

To learn more about SaltMe! snacks please visit www.saltme.com/

 

Tekcapital owns 97% of the share capital of MicroSalt Ltd. and 6,034,683 shares (78%) of MicroSalt Inc., its U.S. subsidiary.

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com.

.

LEI: 213800GOJTOV19FIFZ85

For further information, please contact:

Tekcapital Plc 

 Via Flagstaff IR

Clifford M. Gross, Ph.D. 

SP Angel Corporate Finance LLP (Nominated Adviser and Broker)

+44 (0) 20 3470 0470 

Richard Morrison / Charlie Bouverat (Corporate Finance)

Rob Rees (Corporate Broking)

 

 

Flagstaff Strategic and Investor Communications

Tim Thompson/Andrea Seymour/Fergus Mellon

microsalt@flagstaffcomms.com

 

 

+44 (0)207 129 1474

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving U.S. Salt, MicroSalt and/or Tekcapital that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of U.S. Salt, MicroSalt and/or Tekcapital's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of U.S. Salt, MicroSalt or Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Neither U.S. Salt, MicroSalt nor Tekcapital intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFSVFSIEIIV
Date   Source Headline
12th May 20257:00 amRNSPortfolio Company Update:Guident Corp Proposed IPO
6th May 20257:00 amRNSPortfolio Company Update - Innovative Eyewear Inc.
28th Apr 20257:00 amRNSPortfolio Company Update - Innovative Eyewear Inc
24th Apr 20257:00 amRNSQ1 2025 Business Update
10th Apr 20257:00 amRNS-RInnovative Eyewear Receives EU Certification
31st Mar 20255:34 pmRNSUnaudited Results to 31 December 2024
20th Mar 20257:00 amRNS$0.35m Contract Win
13th Mar 20257:00 amRNSCorporate Update & 2025 Outlook
17th Feb 20257:00 amRNS2024 Review - Year End Portfolio Update
14th Feb 20251:22 pmRNSNotification of Major Holdings
3rd Feb 20257:00 amRNSOversubscribed Fundraising of £2.3Million
30th Jan 20257:00 amRNS-RInnovative Eyewear announces Key Partnership
22nd Jan 202511:14 amRNSNotification of Major Holdings
21st Jan 20257:00 amRNSGuident Receives Significant New Patent Coverage
17th Jan 20259:13 amRNSPlacing of £0.5 million (c.$0.6m)
15th Jan 20257:00 amRNSGuident Corp. Appointment of Investment Banker
20th Dec 20247:00 amRNSPortfolio Company Update - Guident Ltd
4th Dec 20247:00 amRNSIssue of Shares to Advisers
25th Nov 20249:13 amRNS-RPortfolio Company Update - Innovative Eyewear
20th Nov 20244:26 pmRNSNotification of Major Holdings
20th Nov 20247:00 amRNSCorporate Update
15th Nov 20247:00 amRNSFundraising of £1.0 Million
30th Oct 20247:00 amRNSNew and Follow-on B2B Customer Orders
8th Oct 20247:00 amRNSCorporate Update
2nd Oct 20248:00 amRNSTekcapital Spins out GenIP onto AIM
25th Sep 20247:00 amRNSHalf Year Results
18th Sep 20247:58 amRNSGenIP plc Schedule One
16th Sep 20247:00 amRNSMultiple Placements of Products and B2B Progress
13th Sep 20241:37 pmRNSHolding(s) in Company
29th Aug 20247:00 amRNSPortfolio Company Update Innovative Eyewear Inc
13th Aug 20247:00 amRNSInnovative Eyewear 2nd Q24 Revenue increased 82%
1st Jul 202411:21 amRNSGrant of Share Options
21st Jun 20244:20 pmRNSResults of Annual General Meeting
30th May 20247:00 amRNSPortfolio Company Update - Innovative Eyewear
22nd May 20247:00 amRNSFinal Results year ended 31 December 2023
2nd May 20247:00 amRNSPortfolio Company Update Guident Q1 2024
26th Apr 20247:00 amRNSInnovative Eyewear Canadian Partnership
25th Apr 20247:00 amRNSInnovative Eyewear Patent Filings
18th Apr 20247:00 amRNSInnovative Eyewear Signs Brand Ambassador
17th Apr 20247:00 amRNSInnovative Eyewear Distribution Partnership
9th Apr 20247:00 amRNSPortfolio Company Update : Guident Ltd
5th Apr 20247:00 amRNSPortfolio Company Update : Guident Ltd
28th Mar 202410:20 amRNSNotification of Major Holdings
7th Mar 202411:15 amRNSNotification of Major Holdings
6th Mar 20247:00 amRNSIntellectual Property Update
29th Feb 20247:51 amRNSFundraising of £2.0 million
19th Feb 20247:00 amRNSPortfolio Company Update : Guident Ltd
15th Feb 202410:31 amRNSNotification of Major Holdings
15th Feb 20247:00 amRNSGuident Expands its Strategic Partnership
13th Feb 20242:24 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.